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Healthcare systems struggle to deliver care for common
conditions in a cost effective manner while achieving both
optimal outcomes and patient satisfaction. Obvious im-
provements include shortening the time from referral to
treatment and reducing the number of patient episodes. An
ideal single stage pathway for a common surgical condition
would involve direct referral from the general practitioner
(GP) to a clinic where diagnostic tests are undertaken and
treatment (including surgery) is provided, with patients be-
ing able to return home the same day.
Carpal tunnel syndrome (CTS) is the most common
hand disorder with a prevalence of 3–6%.
1,2
Although more
than 40,000 patients undergo surgical decompression in the
UK each year,
3
approximately 0.7% of the population has
undiagnosed CTS that would benefit from surgery, suggest-
ing that the condition is undertreated.
4
Furthermore, over
44% of patients with presumed CTS require in excess of 31
days off work per annum.
5
Analysis of the costs of CTS treatment, including indirect
non-healthcare costs such as loss of productivity caused by
absence from work, led to the conclusion that established
CTS is best treated by surgery.
6
Surgery has also been shown
to be superior to non-operative treatment for patients with
symptoms of CTS without changes due to denervation.
7
These factors have driven the development of efficient
pathways for surgical treatment of the disorder. However,
although the treatment of CTS at a single stage has been
described by a number of authors,
8–10
closer analysis reveals
that the clinical pathways described either involved more
than one visit, mainly because nerve conduction studies
(NCS) required a separate visit, or treatment was provided
without neurophysiological testing.
While there is widespread agreement that NCS are de-
sirable when assessing patients with median nerve symp-
toms,
11
traditional waiting times for neurophysiological tests
lengthen the clinical pathway and prevent the evaluation
and treatment of CTS at a single clinic visit. Recent advanc-
es in diagnostic neurophysiology have greatly simplified the
testing of peripheral nerve function. The automated systems
provide increased availability and the data are comparable
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ABSTRACT
INTRODUCTION Carpal tunnel syndrome is the most common hand disorder. We describe a pathway that includes clinical as-
sessment, neurophysiological testing, surgery and physical therapy all at the same visit.
METhODS All referrals for carpal tunnel syndrome were screened for inclusion in a ‘one-stop’ surgeon-led clinic. Prospective
clinical data collected included patient reported outcome measures and satisfaction scores, touch threshold, pinch and grip
strength. Patients were assessed clinically, underwent nerve conduction studies and surgery as indicated, all on the same day.
Baseline and one-year follow-up data were analysed for 57 patients (62 hands).
RESULTS There was signiﬁcant improvement in all domains of the Boston Carpal Tunnel and Michigan hand Outcomes ques-
tionnaires, grip strength and touch threshold. There were no adverse events. The total mean operating time was 12.8 minutes
(range: 5–15 minutes) and the mean tourniquet time was 2.5 minutes (range: 1–11 minutes). Using a dual theatre model
produced a short mean turnaround time of 14.8 minutes (range: 2–37 minutes). Patient satisfaction as judged using a Picker
questionnaire was very high.
CONCLUSIONS A highly efﬁcient clinical service involving both diagnostics and treatment can be delivered at a single hospital
visit while maintaining optimal outcomes and high patient satisfaction.
Table 1 Patient demographics
Women 47 5 bilateral
Men 10 0 bilateral
Mean age 56 years Range: 27–96 years
Mean body mass index 28.7kg/m
2
Range: 18.1–45.9
Wrist ratio 0.72 Range: 0.61–0.81
Figure 1 Number of patients managed in clinics, shown as
mean numbers in three-month periods
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to those generated by a neurophysiologist using traditional
instrumentation.
12
The availability of validated portable NCS
devices potentially enables a surgeon to provide treatment
based on the history, clinical examination and NCS at a sin-
gle clinic visit.
We describe the one-year outcomes of a ‘one-stop’ clinic
for the management of CTS.
Methods
Referrals from GPs were screened and unsuitable patients,
such as those on warfarin, were routed to the regular outpa-
tient clinics. The remainder were sent an information pack
giving details of the same-day surgery service and including
symptom and hand function questionnaires (Boston Carpal
Tunnel Questionnaire [BCTQ] and Michigan Hand Out-
comes Questionnaire [MHQ]) for pre-operative completion
as well as a patient satisfaction (Picker) questionnaire.
The BCTQ
13,14
is a disease specific patient completed
questionnaire quantifying symptoms and function with
items rated on a scale of 1 to 5. Lower scores imply milder
symptoms and less functional impairment. The MHQ15
measures the domains of pain, function, work, satisfac-
tion and cosmesis. High pain scores indicate greater pain,
while in the other four domains, high scores denote better
hand performance. Patient satisfaction was assessed using
a Picker questionnaire (Appendix 1, published online). The
Picker Institute is an approved survey contractor for Na-
tional Health Service surveys and pioneered measurement
of patient experience surveys.
Patients were also provided with a detailed patient infor-
mation sheet, approved by the local research ethics commit-
tee and including an invitation to participate in outcomes
research, to assist with the consent process on the day of
treatment. In addition, the patients were contacted by the
clinic coordinator to arrange a convenient appointment.
Clinics were held on a Saturday morning and staffed by
a receptionist, a nurse, two consultant surgeons and two
hand therapists. Two operating theatres were staffed by two
theatre nurses and a healthcare assistant. Patients’ weight
and height were measured by nursing staff to calculate
the body mass index (BMI). They were then assessed by a
surgeon and those with clinical signs of CTS were referred
to the hand therapists for evaluation of strength, sensory
thresholds and completion of NCS. Patients who gave their
informed signed consent were recruited to the study.
Wrist ratio (the ratio of wrist depth to width) was meas-
ured with callipers. Grip strength was measured using a
Jamar dynamometer and tip pinch strength using a pinch
gauge.
16
Touch thresholds of the volar thumb and index fin-
gers were evaluated with the Weinstein Enhanced Sensory
Test.
17
The monofilaments provide increasing increments
of pressure. Monofilament values were converted to a five-
point ordinal scale, with the 2.83 monofilament ranked 5
and the 6.65monofilament ranked 1. Themean of the thumb
and index finger scores was analysed to generate the touch
threshold score for the hand. NCS were performed using an
automated portable electrophysiologic device (NeuroMetrix
Inc, Waltham, MA, US). The conduction data were elec-
tronically transmitted and normalised against an age- and
size-matched control database. A report was emailed back
within 15 minutes.
Patients were reassessed by the surgeon and a treat-
ment plan was formulated. Those requiring carpal tunnel
release on the basis of a clear history, positive provocative
signs and abnormal NCS were consented for surgery, given
a bupivacaine median nerve wrist block and ushered to
the surgery bay. Patients were led into the operating rooms
and the arm was prepared and draped by the theatre nurse
before surgery was performed under tourniquet control.
Typically, a 3cm incision in the axis of the fourth ray was
used. The retinaculum was divided and not reconstructed.
Two operating theatres were used to maximise efficiency.
After release of the tourniquet and haemostasis, the inci-
sion was closed with non-absorbable sutures. The nurse
applied dressings while the surgeon wrote the operation
note and dictated a treatment summary letter for the GP.
The sequence was repeated in the adjacent theatre by the
same surgeon, ensuring there was no down time between
procedures.
The patients were seen immediately afterwards by the
hand therapist and received verbal and written instructions
with regard to digital mobilisation and aftercare. A high
sling was fitted. Patients were advised to contact the coor-
dinator with any post-discharge problems and instructed to
return to their GP practice nurse at two weeks for removal
of the sutures. To maximise efficiency, both surgeons as-
sessed patients for the first hour of the clinic, after which
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Table 2 Summary of Boston Carpal Tunnel and Michigan Hand Outcomes questionnaire results
Questionnaires
(n=62 hands)
Baseline median (IQR) 1-year median (IQR)
Boston Carpal Tunnel
(scored 1–5)
Symptom severity score 2.7 (2.4–3.5) 1.5 (1.0–2.0)*
Functional status score 2.4 (1.8–3.2) 1.4 (1.0–2.0)*
Michigan Hand Outcomes
(scored 0–100)
hand function 45 (35–66) 75 (64–88)*
†
Work 60 (35–95) 80 (60–96)**
†
Pain 60 (35–80) 10 (0–36)*
†
Satisfaction 29 (21–46) 84 (57–100)*
Activities of daily living (treatment hand) 70 (35–90) 90 (80–100)*
IQR = interquartile range
Median differences for Boston Carpal Tunnel symptom severity and functional status scores and Michigan hand Outcomes subscales of hand
function, work, pain, satisfaction and activities of daily living at one year compared with baseline scores showed signiﬁcant improvement
(*p<0.0001, **p<0.0010).
†
For patients with carpal tunnel syndrome, clinically signiﬁcant improved Michigan scores were recorded for the domains of function (minimal
clinically important difference of 13), work (8) and pain (23).
29
Table 3 Summary of Boston Carpal Tunnel Questionnaire results at baseline, 3 months and 1 year
Boston Carpal Tunnel
Questionnaire
(scored 0–5)
(n=44 hands)
Baseline median (IQR) 3-month median (IQR) 1-year median (IQR)
Symptom severity score 2.6 (2.3–3.2) 1.6 (1.3–2.1)* 1.5 (1.0–2.0)*
Functional status score 2.1 (1.5–2.9) 1.4 (1.1–2.0)* 1.4 (1.0–2.0)*
IQR = interquartile range
Median difference for both symptom severity and functional status at three months and one year compared with baseline scores showed sig-
niﬁcant improvement (*p<0.0001).
one undertook all the surgery while the other continued
with patient assessment.
Over the one-year period, 249 patients were referred
to the clinic. The majority (n=205, 82%) were diagnosed
with CTS. Of these, 30 were treated by steroid injection for
mild or intermittent symptoms and 175 advised to undergo
surgery. Almost all (n=164, 94% of those recommended sur-
gery) elected to undergo surgery on the same day. Seven
patients deferred surgery to a later date because of work
or family commitments and four declined surgery. Five
patients (2%) reported that their symptoms had resolved at
the time of the consultation and 28 (11%) were diagnosed
as not having CTS requiring treatment or having non-nerve
compressive disorders and referred back to their GP. Eleven
patients (4%) were referred for further formal NCS because
they had symptoms and signs consistent with ulnar nerve
involvement or cervical radiculopathy.
Pre-operative scores of BCTQ andMHQ, touch threshold,
grip and pinch were compared with post-operative values at
1 year for 57 patients (62 hands) using the Wilcoxon signed-
rank test for non-parametric data. Data were analysed using
Prism
®
(GraphPad Software Inc, La Jolla, CA, US). Of the
cohort of 57 patients, 42 patients (44 hands) also completed
a postal BCTQ at 3 months.
Results
A total of 106 patients (120 hands) treated between October
2008 and November 2009 agreed to participate in the study.
Of these, 25 patients (28 hands) were lost to follow up and 1
withdrew. For 23 patients (29 hands) the data were incom-
plete. Complete data at baseline and 1 year were available
for 57 patients (62 hands). The patient demographics are
shown in Table 1.
Carpal tunnel release was performed in 58 hands (3 of
which were revision surgery) and 4 had non-operative treat-
ment comprising steroid (4mg betamethasone) injection
and splintage. The mean operating time was 12.8 minutes
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Table 4 Selected summary of Picker questionnaire results
from 97 patients
Would you recommend this treatment facility to your family and
friends?
Response: Yes, deﬁnitely
86% (n=83)
Yes, probably
11% (n=11)
Overall, how would you rate the care you received at the depart-
ment?
Response: Excellent
65% (n=63)
Very good
28% (n=27)
How well organised was the department you visited?
Response: Very well
81% (n=79)
Fairly well
16% (n=16)
Table 5 Summary of physical measurements
Assessment
(n=62 hands)
Baseline
median (IQR)
1-year median
(IQR)
Grip treatment hand (kg)
Pinch (kg)
15.0 (5.8–24.0)
3.4 (2.5–5.0)
23.0 (16.0–28.0)*
4.5 (4.0–6.1)*
WEST touch threshold
hand 4.0 (3.4–4.5) 4.5 (4.0–5.0)*
IQR = interquartile range; WEST = Weinstein Enhanced Sensory Test
Median difference for grip and pinch strength and touch threshold at
one year compared with baseline scores showed signiﬁcant improve-
ment (*p<0.0001).
(range: 5–15 minutes) and the mean tourniquet time was 2.5
minutes (range: 1–11 minutes). The mean turnaround time
for patients from entering to leaving the operating theatre
was 14.8 minutes (range: 2–37 minutes). These times pro-
gressively reduced as the service becamemore streamlined.
Statistically significant improvements were achieved
in all domains of both questionnaires (Table 2). While the
BCTQ score at 3 months after surgery improved significant-
ly from the baseline score, there was little further improve-
ment up to 12 months (Table 3). The patient satisfaction
scores using Picker surveys were overwhelmingly positive
and selected domains are shown in Table 4. Significant
improvements were achieved in all physical measures of
grip, pinch and touch threshold (Table 5). Grip strength in-
creased by over 40%. Eight patients (14%) requested advice
on scar management or had queries regarding the duration
of post-operative recovery of sensation and function. The
number of patients treated per clinic increased steadily as
the pathway became established (Fig 1).
Discussion
Drivers for changes to healthcare delivery include qual-
ity, hospital efficiency and enhanced patient experiences.
Improvements in quality or at least maintenance of the
current standards must accompany any alterations in the
provision of healthcare. Although the one-stop clinic model
for the management of CTS has been described previously,
to our knowledge this study reports on the first true one-
stop clinic whereby clinical assessment, NCS and surgical
treatment are completed on the same day. Our data show
that at one year there was a significant improvement in
absolute indicators of hand function such as pinch grip
and digital tip sensation and our results compare favour-
ably with previous studies.
18
Patient reported outcomes are
important indicators of change; the MHQ showed clinically
significant improvement in all domains and the improve-
ments in the BCTQ were equivalent to those published by
other centres.
19,20
There was no further improvement in symptoms using
the BCTQ between three months and one year after carpal
tunnel release, suggesting that future studies could be
conducted with only a three-month follow-up period. This
may reduce the loss of patients. Mallick et al also found that
there was no significant improvement in the BCTQ scores
between two and six months after treatment.
21
Almost half
of the patients enrolled in the study were lost to follow up
and it is therefore possible that our data are not representa-
tive of the entire group.
Twelve patients were unwilling to attend one-year
follow-up appointments due to transport difficulties. They
completed questionnaires but were not included in the
analysis due to lack of physical measurement data. A further
15 provided incomplete baseline MHQs. This suggests that
the MHQ may have been perceived as being too onerous
to complete. While some studies have reported follow-up
rates in excess of 95%
18,19,22
several UK-based studies have
reported rates similar to ours.
20,23,24
Our population was very
similar in demographics to that described by Farmer and
Davis
25
with regard to age, BMI and wrist ratio and, there-
fore, representative of patients presenting with CTS in other
parts of the UK.
While we cannot be certain that all patients who devel-
oped any adverse events were identified as there were no
early post-operative follow-up visits, of those who complet-
ed the study follow-up period, only eight required additional
advice regarding scar management. No patients required
readmission.
Our single stage treatment pathway allows up to 25 pa-
tients to be treated in 4 hours by experienced consultant sur-
geons with short average operating times in a dual theatre
model that minimises patient turnaround times. However,
operating on CTS on a day case basis alone does not realise
substantially improved benefits. A review of day theatre use
in our hospital revealed that only 4–6 procedures on aver-
age were performed on a 4-hour operating list dedicated
to carpal tunnel patients. Effective theatre use can realise
substantial savings and optimising theatre usage is probably
the largest single efficiency improvement for a hospital as
each hour of theatre time costs £1,200.
26
The successful treatment of large numbers of patients
with CTS has had the additional benefit of releasing week-
day theatre availability, leading to a reduction in waiting
times for other procedures. Furthermore, holding the one-
stop clinic on a Saturday utilises theatre and clinic facilities
that are normally unused at weekends.
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Importantly, the single stage management of CTS sig-
nificantly improved capacity in other hospital departments.
The introduction of NCS in the one-stop clinic has led to a
fall in the number of referrals to the neurophysiology de-
partment for conventional NCS in our trust by 30%. Patients
with CTS are the largest group referred to neurophysiology
services
11
and reducing CTS referrals improves the waiting
times for NCS of more complex neurological conditions.
Following the introduction of the single stage clinic, refer-
rals of patients with CTS to hand therapy reduced by 53%
compared with the previous year, again increasing capacity
for patients with complex hand conditions.
Delivering high quality care while reducing events that
do not add value to patients, such as unnecessary hospital
attendances, is becoming increasingly important.
27
The
Picker scores of patients attending the one-stop clinic re-
vealed an overwhelmingly positive response to the service.
Our single stage treatment represents a true one-stop clinic
and includes assessment, NCS, surgery and post-operative
education on aftercare by a hand therapist, avoids unneces-
sary attendances and contrasts sharply with the traditional
pathway where the patient attends on multiple occasions
and often has a considerable waiting time for NCS.
11
Previous descriptions of surgeon-led accelerated path-
ways for CTS
7,9
did not include NCS. Many surgeons do not
routinely request NCS and base their management plan on
clinical assessment alone. The desirability of data from NCS
in patients with CTS remains controversial. However, there
are data suggesting that neurophysiological studies com-
bined with clinical assessment improves the specificity for
diagnosis of CTS to 85% (sensitivity: 90%) compared with
40% for clinical assessment alone.
28
Although the use of a
portable NCS system increases the clinical assessment by
approximately 15 minutes, portable NCS devices overcome
the long waiting times associated with traditional NCS while
providing the added benefit of enhanced clinical decision
making.
Conclusions
Over the last six months we have extended the indications
for referral to our one-stop clinic to include other simple
hand disorders such as trigger digits. Our data suggest that
the single stage paradigm could be applied successfully to
many simple surgical conditions and especially disorders of
the hand.
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